Share-based Payment Arrangement, Expense of Sana Biotechnology, Inc. from 31 Dec 2019 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Sana Biotechnology, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2019 to 31 Dec 2025.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $6,337,000, a 1.5% decline year-over-year.
  • Sana Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $25,464,000, a 32% decline year-over-year.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2025 was $25,464,000, a 32% decline from 2024.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $37,678,000, a 6% increase from 2023.
  • Sana Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $35,533,000, a 7.3% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Sana Biotechnology, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $25,464,000 $6,337,000 -$99,000 -1.5% 01 Oct 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
Q3 2025 $25,563,000 $5,476,000 -$5,294,000 -49% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $30,857,000 $6,629,000 -$4,751,000 -42% 01 Apr 2025 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $35,608,000 $7,022,000 -$2,070,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $37,678,000 $6,436,000 -$1,495,000 -19% 01 Oct 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
Q3 2024 $39,173,000 $10,770,000 +$1,767,000 +20% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $37,406,000 $11,380,000 +$1,532,000 +16% 01 Apr 2024 30 Jun 2024 10-Q 11 Aug 2025 2025 Q2
Q1 2024 $35,874,000 $9,092,000 +$341,000 +3.9% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $35,533,000 $7,931,000 -$2,660,000 -25% 01 Oct 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY
Q3 2023 $38,193,000 $9,003,000 -$1,077,000 -11% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $39,270,000 $9,848,000 -$63,000 -0.64% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $39,333,000 $8,751,000 +$996,000 +13% 01 Jan 2023 31 Mar 2023 10-Q 08 May 2024 2024 Q1
Q4 2022 $38,337,000 $10,591,000 +$3,278,000 +45% 01 Oct 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
Q3 2022 $35,059,000 $10,080,000 +$4,130,000 +69% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023 2023 Q3
Q2 2022 $30,929,000 $9,911,000 +$4,970,000 +101% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $25,959,000 $7,755,000 +$3,597,000 +87% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q4 2021 $22,362,000 $7,313,000 +$4,522,000 +162% 01 Oct 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
Q3 2021 $17,840,000 $5,950,000 +$4,784,000 +410% 01 Jul 2021 30 Sep 2021 10-Q 02 Nov 2022 2022 Q3
Q2 2021 $13,056,000 $4,941,000 +$3,825,000 +343% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $9,231,000 $4,158,000 +$3,403,000 +451% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $5,828,000 $2,791,000 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2023 2022 FY
Q3 2020 $1,166,000 01 Jul 2020 30 Sep 2020 10-Q 08 Nov 2021 2021 Q3
Q2 2020 $1,116,000 01 Apr 2020 30 Jun 2020 10-Q 04 Aug 2021 2021 Q2
Q1 2020 $755,000 01 Jan 2020 31 Mar 2020 10-Q 05 May 2021 2021 Q1

Sana Biotechnology, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $25,464,000 -$12,214,000 -32% 01 Jan 2025 31 Dec 2025 10-K 03 Mar 2026 2025 FY
2024 $37,678,000 +$2,145,000 +6% 01 Jan 2024 31 Dec 2024 10-K 03 Mar 2026 2025 FY
2023 $35,533,000 -$2,804,000 -7.3% 01 Jan 2023 31 Dec 2023 10-K 03 Mar 2026 2025 FY
2022 $38,337,000 +$15,975,000 +71% 01 Jan 2022 31 Dec 2022 10-K 17 Mar 2025 2024 FY
2021 $22,362,000 +$16,534,000 +284% 01 Jan 2021 31 Dec 2021 10-K 29 Feb 2024 2023 FY
2020 $5,828,000 +$4,331,000 +289% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2023 2022 FY
2019 $1,497,000 01 Jan 2019 31 Dec 2019 10-K 16 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.